Jessica Robinson

Aug 26, 2024 | cairnspost.com.au | Jessica Robinson

The Tasmania JackJumpers have locked in a roster to chase back-to-back glory coming off the NBL24 Championship title. They’ve bolstered their squad with NBL talent and American imports, however were thrown a curveball as star players caught the eyes of the NBA. Finals MVP Jack McVeigh – the man who hit ‘The Shot’ – is off to Houston on a two-way deal. And it’s only a matter of time until Will Magnay gets snatched up after his Olympic debut.

Aug 26, 2024 | townsvillebulletin.com.au | Jessica Robinson

The Tasmania JackJumpers have locked in a roster to chase back-to-back glory coming off the NBL24 Championship title. They’ve bolstered their squad with NBL talent and American imports, however were thrown a curveball as star players caught the eyes of the NBA. Finals MVP Jack McVeigh – the man who hit ‘The Shot’ – is off to Houston on a two-way deal. And it’s only a matter of time until Will Magnay gets snatched up after his Olympic debut.

Aug 26, 2024 | codesports.com.au | Jessica Robinson

The Tasmania JackJumpers have locked in a roster to chase back-to-back glory coming off the NBL24 Championship title. They’ve bolstered their squad with NBL talent and American imports, however were thrown a curveball as star players caught the eyes of the NBA. Finals MVP Jack McVeigh – the man who hit ‘The Shot’ – is off to Houston on a two-way deal. And it’s only a matter of time until Will Magnay gets snatched up after his Olympic debut.

May 7, 2024 | wealthinsidermag.com | Jessica Robinson

Investing.com — Apple’s trajectory for its artificial intelligence ambitions remains “uncertain” after the tech giant’s latest quarterly results, according to analysts at PhillipCapital. In a call with analysts last week, Chief Executive Tim Cook hinted that Apple (NASDAQ:) would soon be sharing “some very exciting things with our customers” regarding its advances in so-called generative AI.

Sep 5, 2023 | acsjournals.onlinelibrary.wiley.com | Corey Tsang |Jessica Robinson |Paul Wheatley-Price |Stephanie Y. Brule

Paclitaxel has a risk of infusion-related reactions (IRRs) and despite no prospective evidence, is often given with premedication including a corticosteroid, H1 antagonist, and H2 antagonist (H2RA). Backorders impacted the supply of intravenous H2RAs at our center, and it was removed as routine premedication. The authors compared the incidence of IRR in patients treated without H2RA to patients receiving standard H2RA premedication.